← SynDRA
CLINOFIBRATE
SynDRA canonical compound SYN0028070 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | LPL |
|---|
| Mechanism of action | Lipase clearing factor inhibitor |
|---|
| Indication | hypertriglyceridemia |
|---|
| Disease area | endocrinology |
|---|
All known targets
Mechanisms of action (all sources)
- Lipase clearing factor inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ADORA1
- NR3C1
- HTR1A
- HTR2A
- HTR2B
- HTR2C
- HTR3A
- KCNH2
- MAOA
- MC3R
- MLNR
- NPY1R
- NR1I2
- OPRD1
- HRH2
- OPRK1
- OPRM1
- PDE3A
- PDE4D
- PGR
- PTGS2
- SLC29A1
- SLC6A2
- SLC6A3
- SLC6A4
- TBXA2R
- HRH3
- HRH1
- ADORA2A
- CCKAR
- ADORA3
- ADRA1A
- ADRA2A
- ADRA2B
- ADRA2C
- ADRB1
- ADRB2
- AGTR1
- AVPR1A
- AVPR2
Cross-references
Synonyms
- lipoclin
- S 8527
- Clinofibrato
- Lipoclin
- Clinofibratum
- DTXCID4026638
- 1,1-bis(4'-(1''-carboxy-1''-methylpropoxy)phenyl)cyclohexane
- RefChem:577719
- MFCD00865769
- NCGC00167453-01
- NCGC00167453-02
- Clinofibrate [INN:JAN]
- Clinofibratum [INN-Latin]
- Clinofibrato [INN-Spanish]
- CAS-30299-08-2
- BRN 2230067
- UNII-0374EZJ8CU
- Lipoclin (TN)
- CLINOFIBRATE [MI]
- CLINOFIBRATE [INN]
- CLINOFIBRATE [JAN]
- Clinofibrate (JP18/INN)
- SCHEMBL31290
- CLINOFIBRATE [MART.]
- MLS006010186
- CLINOFIBRATE [WHO-DD]
- orb1300759
- CHEBI:31412
- HMS3656N09
- HMS5081H13
- Tox21_112457
- s2664
- AKOS015896391
- Tox21_112457_1
- AC-4728
- CCG-269436
- CS-6464
- NCGC00167453-03
Look up CLINOFIBRATE in the interactive SynDRA portal →